As a pediatrician, you are on the front line of acne treatment for neonates, children, and adolescents. Acne is a very common condition that will affect 80% of your patients at some point in their lives. It can be easy to diagnose, but acne is often difficult to evaluate and manage. Presentations vary from mild to severe, and you’re likely to see a wide range of acne severity as you treat babies, children, and adolescents through office consultations and regular wellness checks. Minimal...

NEW YORK (EGMN) – Rituximab may offer an alternative treatment for children whose juvenile dermatomyositis does not respond to available therapies, depending on the outcome of an ongoing trial, Dr. B. Anne Eberhard said at a meeting sponsored by New York University.There are no U.S. Food and Drug Administration–approved medications for juvenile dermatomyositis (JDM).The RIM (Rituximab in Myositis) trial is a randomized, phase II, placebo-phase controlled, multicenter trial investigating the...